AI predicts future pancreatic cancer

AI model spots those at highest risk for up to three years before diagnosis

16-May-2023 - An artificial intelligence tool has successfully identified people at the highest risk for pancreatic cancer up to three years before diagnosis using solely the patients’ medical records, according to new research led by investigators at Harvard Medical School and the University of Copenhagen, in ...

New blood test detects wide range of cancers

Test proved able to detect and indicate site of dozens of types of cancer with high accuracy

03-Apr-2020 - In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic. The results, ...

New cancer immunotherapy approach combines tumor fighting power with fewer side effects

18-May-2016 - Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the shortcomings associated with other methods, scientists at Dana-Farber Cancer Institute report in a new study in the Proceedings of the National ...

New view of stomach cancer could hasten better therapies

Study defines four biological subtypes that could guide clinical trials

29-Jul-2014 - In a massive effort to catalog the molecular causes of stomach cancer, scientists, including researchers at Dana-Farber Cancer Institute, have identified four subtypes of tumors based on shared mutations and other molecular abnormalities. They say the new classification promises to advance ...

Antibody halts cancer-related wasting condition

Study pinpoints a molecular cause of cachexia, and hints at a potential treatment

15-Jul-2014 - New research raises the prospect of more effective treatments for cachexia, a profound wasting of fat and muscle occurring in about half of all cancer patients, raising their risk of death, according to scientists from Dana-Farber Cancer Institute. Many strategies have been tried to reverse the ...

Belfer Institute and Evotec establish collaboration in oncology

02-May-2013 - The Belfer Institute for Applied Cancer Science at Dana-Farber Cancer Institute and Evotec AG (EVT) announced a research collaboration aimed at discovering and commercialising novel cancer treatments based on epigenetic drug mechanisms. The goal of the collaboration is to validate emerging ...

Researchers shine light on how some melanoma tumors evade drug treatment

29-Nov-2010 - Researchers shine light on how some melanoma tumors evade drug treatment Findings pinpoint a critical gene involved in melanoma growth, provide a framework for discovering ways to tackle cancer drug resistance The past year has brought to light both the promise and the frustration of developing ...

Molecular discovery suggests new strategy to fight cancer drug resistance

Prototype drug blocks MCL-1 protein that helps tumors survive treatment

23-Jun-2010 - Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy treatment of several major forms of cancer. The researchers discovered, surprisingly, that they could exploit a small portion of this anti-death protein, called MCL-1, to make a ...

Genes found linked to breast cancer drug resistance could guide future treatment choices

26-Jan-2010 - Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs. Despite their resistance to drugs of the anthracycline class, the breast ...

Study pinpoints novel cancer gene and biomarker

26-Jun-2009 - Dana-Farber Cancer Institute scientists' discovery of a cancer-causing gene – the first in its family to be linked to cancer – demonstrates how the panoramic view of genomics and the close-up perspective of molecular biology are needed to determine which genes are involved in cancer and which are ...